Expanding treatment options in LAA closure patients - WATCHMAN™
Chairpersons: T. FELDMAN, D. HILDICK-SMITH
Objectives:
To learn which patients benefit from LAA and how to balance best the risk of stroke and bleedingTo know the latest clinical data and guidelines for LAA closure
To understand the expected benefits of WATCHMAN™ in complex anatomies
Lectures
Session objectives
T. Feldman
Case 1: my 90-year-old male patient with afib and CAD and hypertension develops haematuria on Rivaroxaban
D. Foley
Case 2: my patients have challenging LAA anatomies and a high bleeding risk
M. Sandri
Case 3: my patient cannot take warfarin - not even for six weeks
M.W. Bergmann